/PRNewswire/ PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that PacBio s Compensation.
/PRNewswire/ PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023. Second quarter results Revenue of $47.6 million, a.
Pacific Bio (PACB) to Acquire Apton Biosystems streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PacBio will Combine Apton s Proprietary Sequencing Technology With its Highly Accurate Sequencing by Binding Chemistry to Develop a High-Throughput Sequencer Designed to Deliver Billions of Reads.